All of the aforementioned information supports the conclusion that GAS5 promotes apoptosis, suppresses metastasis, enhances sensitivity to a number of drugs, and increases the survival rate of breast cancer patients, including TNBC, through the participation of some mechanisms according to the ceRNA model (Figure 2). The gene discussed is GAS5; the disease is breast carcinoma.